The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection.
In 2008, the Netherlands Association of Gastroenterologists and Hepatologists (Nederlands Vereniging van Maag-Darm-Leverartsen) published the Dutch national guidelines for the treatment of chronic hepatitis B virus infection. New insights into the treatment of chronic hepatitis B with relevance for clinical practice have been adopted in these concise, revised guidelines. The most important changes include the choice of initial antiviral therapy, licensing of tenofovir for the treatment of chronic hepatitis B and the management of antiviral resistance.
Department of Gastroenterology and Hepatology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
E H C J
EH
Buster
B C
BC
Baak
C M
CM
Bakker
U H W
UH
Beuers
J T
JT
Brouwer
J P H
JP
Drenth
K J
KJ
van Erpecum
B
B
van Hoek
P
P
Honkoop
M J
MJ
Kerbert-Dreteler
G H
GH
Koek
K M J
KM
van Nieuwkerk
H
H
van Soest
B W
BW
van der Spek
A C I T L
AC
Tan
J M
JM
Vrolijk
H L A
HL
Janssen
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000592:standards / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000592:standards / Q000627:therapeutic use; D017277:Drug Approval; D024882:Drug Resistance, Viral / Q000187:drug effects*; D005260:Female; D006147:Guanine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000592:standards / Q000627:therapeutic use; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D019259:Lamivudine / Q000592:standards / Q000627:therapeutic use; D008895:Milk, Human / Q000187:drug effects; D009426:Netherlands; D009705:Nucleosides / Q000008:administration & dosage / Q000627:therapeutic use; D063065:Organophosphonates / Q000008:administration & dosage / Q000592:standards / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D051437:Renal Insufficiency / Q000188:drug therapy / Q000209:etiology; D000077712:Telbivudine; D000068698:Tenofovir; D013936:Thymidine / Q000031:analogs & derivatives / Q000592:standards / Q000627:therapeutic use
D000998:Antiviral Agents; D009705:Nucleosides; D063065:Organophosphonates; D000077712:Telbivudine; D019259:Lamivudine; C413685:entecavir; D006147:Guanine; C053001:adefovir; D000068698:Tenofovir; D000225:Adenine; D013936:Thymidine